Pharma Journalist 8778 posts 0 comments

Merck announced that the company is beginning two Phase 3 studies of PCV-15 (V114), its investigational polyvalent conjugate vaccine for the prevention of pneumococcal disease. The…
Read More...

SAMDI Tech, Inc. has partnered with Enamine to expand the number of molecules in their small molecule compound libraries. Through the partnership, SAMDI Tech will be able to offer its…
Read More...

Shire plc announces that it has entered into a definitive agreement with Servier S.A.S. to sell its Oncology business for $2.4 billion. Shire's Oncology business includes in-market…
Read More...

PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced that it has signed a collaborative agreement with Plexxikon Inc., the…
Read More...

Cardurion Pharmaceuticals announced it has entered an exclusive licensing agreement with Astellas to develop and commercialize CRD-733, a PDE-9 inhibitor with the potential to improve…
Read More...

Sobi has received approval from Health Canada for a reduced dosing frequency for Orfadin (nitisinone). Orfadin is approved in combination with dietary restriction of tyrosine and…
Read More...

SMi Reports: The past attendee list has just been released in advance of the 8th annual BioBanking conference, taking place this June in London, UK SMi’s 8th annual BioBanking…
Read More...

Boehringer Ingelheim and Eli Lilly and Company announced an academic collaboration with the University of Oxford to investigate the effects of Jardiance on the progression of kidney…
Read More...

Almac Group announced that it has expanded its US commercial packaging capabilities at its Audubon, PA facility. Addressing increased client demand of developing and bringing more…
Read More...

THE NEED FOR ADVANCED CAPABILITIES IN THE BOOMING PHARMACEUTICAL FREEZE DRYING MARKET An understanding in critical factors such as drug consistency, product quality, biological…
Read More...